Table 3.
Week 0a | Week 1b | Week 2b | Week 3c | Week 4c | ||
---|---|---|---|---|---|---|
CCS | IFC group (n = 58) | 14.16 ± 2.03 | 11.40 ± 2.13 | 9.18 ± 1.81 | 9.72 ± 1.59 | 9.81 ± 1.67 |
Control group (n = 60) | 13.93 ± 1.83 | 11.63 ± 1.98 | 9.56 ± 1.79 | 10.04 ± 1.47 | 11.12 ± 1.73 | |
P1 value | .397 | .428 | .142 | .148 | .000 | |
PAC-QoL | IFC group (n = 58) | 39.15 ± 4.83 | 32.47 ± 4.84 | 27.78 ± 5.89 | 29.15 ± 6.16 | 29.83 ± 6.64 |
Control group (n = 60) | 38.89 ± 4.37 | 33.53 ± 4.97 | 29.10 ± 6.02 | 30.36 ± 6.88 | 31.87 ± 6.58 | |
P2 value | .688 | .130 | .119 | .195 | .031 | |
NRS | IFC group (n = 58) | 3.29 ± 0.66 | 3.16 ± 0.60 | 2.88 ± 0.63 | 2.84 ± 0.62 | 2.77 ± 0.49 |
Control group (n = 60) | 3.40 ± 0.65 | 3.28 ± 0.59 | 3.11 ± 0.68 | 3.02 ± 0.64 | 2.96 ± 0.57 | |
P3 value | .221 | .170 | .013 | .041 | .011 |
Abbreviations: CCS, Cleveland Constipation Scales; PAC-QoL, Patient Assessment of Constipation Quality of Life; NRS, pain Numeric Rating Scales; IFC, interferential current.
Outcomes at baseline.
Outcomes of treatment on.
Outcomes of treatment off.